Entity

Time filter

Source Type


Dikshit R.P.,Tata Memorial Hospital | Mathur G.,Tata Memorial Hospital | Mhatre S.,Tata Memorial Hospital | Yeole B.B.,Population Based Cancer Registry
Indian Journal of Medical and Paediatric Oncology | Year: 2011

Stomach cancer is the one of the leading cause of cancer in southern region of India. Its incidence is decreasing worldwide yet on global scale stomach cancer remains one of the most common causes of cancer death. Etiology of gastric cancer includes Helicobacter pylori infection, diet and lifestyle, tobacco, alcohol and genetic susceptibility. In this review, we tried to find the contribution of Indian scientist in understanding the descriptive and observational epidemiology of stomach cancer. PubMed was used as a search platform using key words such as "stomach cancer, treatment, clinical characteristics, stomach cancer outcome, epidemiology, etiological factor and their corresponding Mesh terms were used in combination with Boolean operators OR, AND". Most of the reported studies on gastric cancer from India are case report or case series and few are case-control studies. Indian studies on this topic are limited and have observed H. pylori infection, salted tea, pickled food, rice intake, spicy food, soda (additive of food), tobacco and alcohol as risk factors for gastric cancer. More research is required to understand the etiology, develop suitable screening test, to demarcate high-risk population and to develop and evaluate the effect of primary prevention programs. Source


Lodha R.S.,LN Medical College | Nandeshwar S.,Community Medicine | Pal D.K.,Community Medicine | Shrivastav A.,Population Based Cancer Registry | And 4 more authors.
Asian Pacific Journal of Cancer Prevention | Year: 2011

Background: Breast cancer is the most common cancer in females worldwide, and the second leading cause of cancer deaths in women. The incidence is on the rise in India, and breast cancer is the second most common malignancy in Indian women. Objective: To assess the risk factors for breast cancer patients living in Bhopal. Study Design and Method: This case-control study was conducted in Bhopal urban agglomerate for a period of a year from October 2008 to August 2009. Demographic data and reproductive risk factor related information was collected using a structured questionnaire with analyses by Epi-info and SPSS 16. Results: A history of oral contraceptive pill use (OR=2.77, 95% CI: 1.15-6.65), history of not having breastfeeding (OR=3.49, 95% CI:1.22-9.97), over weight (OR=0.11, 95%CI:0.02-0.49), obese women (OR=0.24, 95%CI: 0.06-0.88) and family history of breast cancer (OR=3.89, 95% CI: 1.01-14.92) were associated significantly with the occurrence of breast cancer on multivariate analysis. Conclusions: The findings of the present study suggests that positive family history of breast cancer and history of using OCP may be the epigenetic factors promoting the occurrence of breast cancer while breastfeeding reduces the possibility of acquiring breast cancer. Source


Hager B.,TU Dresden | Kraywinkel K.,Robert Koch Institute | Keck B.,Friedrich - Alexander - University, Erlangen - Nuremberg | Katalinic A.,University of Lubeck | And 5 more authors.
Radiotherapy and Oncology | Year: 2015

Introduction Aim of the study was to analyze changes in primary treatment for low-risk prostate cancer across different healthcare systems. Materials and methods We compared "Surveillance Epidemiology and End Results" data (USA) with data from four German federal epidemiological cancer registries, both from 2004 to 2011. We excluded metastatic disease and patients aged ≥80 years. Thereof, we identified 132,506 (USA) and 54,159 (Germany) patients with low-risk according to the 2014 EAU guidelines. We tested treatment trends for statistical significance with a linear regression model. Results Active treatment was radical prostatectomy (RP) in 36.1% vs. 66.2% and radiotherapy (RT) in 38.4% vs. 11.8%. No active treatment (NAT) was reported in 24.2% vs. 16.2% (p < 0.001 each). Through the study period the use of RP decreased from 37.1% to 34.2% in the USA (p = 0.04) and was constant at a mean of 66.2% in Germany (p = 0.8). The use of RT in the USA decreased from 42.8% to 31.8% (p < 0.001), while it was stable in Germany (p = 0.09). The NAT group grew from 18.0% to 33.2% in the USA (p < 0.001), while it was stable in Germany until 2009 (p = 0.3). From 2009 to 2011 there also was an increase of the NAT group in Germany from 15.2% to 19.4% (p = 0.001). Conclusion In contrast to former evidence we found the relative use of RT for low-risk prostate cancer much higher in the USA compared to Germany. The implementation of integrated prostate cancer centers in the USA might explain this observation. Deferred and defensive treatment strategies showed a steady increase in the USA. This development seems delayed in Germany by several years. © 2015 Elsevier Ireland Ltd. All rights reserved. Source


Bal M.S.,Government of Punjab | Bodal V.K.,Government of Punjab | Kaur J.,Population Based Cancer Registry | Kaur M.,Government of Punjab | Sharma S.,Population Based Cancer Registry
Asian Pacific Journal of Cancer Prevention | Year: 2015

The State of Punjab has been in focus because of aperceived increasing rate of cancer. Both print and electronic media have created an impression that Punjab, especially the cotton belt of Malwa Region, has become a high incidence cancer region. Actually the increased number of cancer patients might be at least partly because of increasing population and heightened health awareness and reporting. The purpose of this study is to find out the pattern of cancer amongst patients registered in Mukh Mantri Punjab Cancer Rahat Kosh Scheme (MMPCRKS), under cancer registry at Rajindra Hospital Patiala from the various districts of Punjab. The study covers 500 cancer patients registered under MMPCRKS at Rajindra Hospital Patiala, for free cancer treatment. Information regarding age, gender, religion, method of diagnosis and affected sites was obtained. Results were analyzed statistically. Of the 500 patients, 65% were females and 35% were males. The most affected female age groups were 50-54 and 60-64; while males in the age groups of 65-69 and 60-64 had the highest risk. The leading cancers in females were breast followed by cervix and ovary where as in males they were were colon followed by esophagus and tongue. The commonest histological type was adenocarcinoma followed by squamous cell carcinoma. The increasing trend of cancer in Punjab is alarming. Since this study is a preliminary investigation, it could provide a leading role in prevention, treatment and future planning regarding cancer in Punjab. Source


Dikshit R.P.,Tata Memorial Hospital | Nagrani R.,Tata Memorial Hospital | Yeole B.,Population Based Cancer Registry | Koyande S.,Population Based Cancer Registry | Banawali S.,Tata Memorial Hospital
Indian Journal of Medical and Paediatric Oncology | Year: 2011

Background: Little is known about burden of chronic myeloid leukemia (CML) in India. There is a recent interest to observe incidence and mortality because of advent of new diagnostic and treatment policies for CML. Materials and Methods: We extracted data from the oldest population-based cancer registry of Mumbai for 30 years period from 19762005 to observe incidence and mortality rates of CML. We classified the data into four age groups 014, 1529, 3054 and 5574 to observe incidence rates in the respective age groups. Results: The age specific rates were highest for the age group of 5574 years. No significant change in trends of CML was observed for 30 years period. However, there was a significant reduction in incidence rate for recent 15-years period (Estimated average annual percentage change=-3.9). No significant reduction in mortality rate was observed till 2005. Conclusion: The study demonstrates that age-specific rates for CML are highest in age group of 55-74 years, although they are lower compared to western populations. Significant reduction in incidence of CML in recent periods might be because of reduced misclassification of leukemias. The data of CML has to be observed for another decade to witness reduction in mortality because of changes in treatment management. Source

Discover hidden collaborations